TIM-3 transgenic mice developed more severe pulmonary fibrosis compared to wild-type mice, but after macrophage depletion, the fibrosis score was significantly reduced in both wild-type and TIM-3 transgenic mice. This evidence concerns the gene HAVCR2 and pulmonary fibrosis.